Search - tctmd.com

Displaying 1 - 20 of 56

Sort: Relevancy | Date

Presentation TCT 2021

LAAO in 2030: My 5 Top Predictions for the Field

Presenter: David Holmes Jr.

November 06, 2021

Presentation TCT 2021

Closing Complex Anatomies LAAO Devices

Presenter: Brian Whisenant

November 06, 2021

Presentation TCT 2021

Patient Anatomical Selection for LAAO: Should There Be Imaging Consensus Anatomical Criteria?

Presenter: Dee Dee Wang

November 06, 2021

Presentation TCT 2021

Equipoise Is a Myth: NOACs Will Be Superior to LAAO

Presenter: Renato D. Lopes

November 06, 2021

Presentation TCT 2021

ICE Imaging Is Not Ready for Prime-Time: TEE Should Be the Default Approach

Presenter: Brijeshwar Maini

November 06, 2021

Presentation TCT 2021

ICE Imaging Should Be the Default Approach to LAAC Procedural Imaging

Presenter: Mohamad A. Alkhouli

November 06, 2021

Presentation TCT 2021

Oral Anticoagulation Should Be the Default Strategy After LAAC

Presenter: Matthew J. Price

November 06, 2021

Presentation TCT 2021

Antiplatelet Therapy Is Sufficient for DRT Prevention After LAAC

Presenter: Jacqueline Saw

November 06, 2021

Presentation TCT 2021

PRAGUE-17: Three-Year Outcomes From a Randomized Trial of Left Atrial Appendage Closure Versus Direct Acting Oral Anticoagulation in Patients With Atrial Fibrillation

Presenter: Pavel Osmancik

November 05, 2021

Presentation TCT 2021

Captis: Full-Body Embolic Protection Device

Presenter: Haim Danenberg

November 04, 2021

Presentation TCT 2021

Cerebral Protection in TAVR: The PROTEMBO C Trial

Presenter: Tobias Schmidt

November 04, 2021

Presentation TCT 2021

LAA Closure with the Laminar Device: technology and Clinical Update

Presenter: Jason H. Rogers

November 04, 2021

World’s First Dedicated 3D Sizing LAA Exclusion Device (Paladin Medical’s Trinity System)

Presentation TCT 2021

Introducing XCLUDE Integrated Solution. World's First Dedicated LAA 3D Sizing Device and Next-Gen LAA Exclusion Device

Presenter: Flavio Airoldi

November 04, 2021

Presentation TCT 2021

Next Generation LAA Exclusion System to Reduce Stroke Risk in AF Patients (Append)

Presenter: Zachi Berger

November 04, 2021

Presentation TCT 2021

Featured Lecture: Clinical Outcomes of LAAO versus NOACS in Atrial Fibrillation in Patients with Prior Ischemic Stroke: Is There Room for Improvement in Clinical Outcomes?

Presenter: Jens Erik Nielsen-Kudsk

November 04, 2021

Presentation TCT 2021

TCT 703: Concomitant Transcatheter Mitral-Valve-in-Valve (MViV) with Left Atrial Appendage (LAA) Occlusion Device in a High-Risk Patient Unable to Tolerate Anticoagulation

Presenter: Peter Sayegh

November 04, 2021

Presentation TCT 2021

TCT 692: Percutaneous Left atrial appendage occlusion after failed surgical closure with Left Atrial Appendage Epicardial Clip

Presenter: Kofi Ansah

November 04, 2021

Presentation TCT 2021

TCT 691: Percutaneous Closure of Left Atrial Appendage With Suture Dehiscence Using ASD Closure Device Guided by a Novel Live 3D-ICE Probe

Presenter: Amani Khalouf

November 04, 2021

Presentation TVT 2021

Percutaneous Left Atrial Appendage Closure Versus Oral Anticoagulation for Non-Valvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Presenter: Yousif Ahmad

July 22, 2021

Presentation TVT 2021

Right Ventricular-Pulmonary Arterial Coupling and Afterload Reserve in Patients Undergoing Transcatheter Tricuspid Valve Therapy: Insights From the International TriValve Registry

Presenter: Michael Brener

July 22, 2021

Advertisement

LAAO in 2030: My 5 Top Predictions for the Field

Closing Complex Anatomies LAAO Devices

Patient Anatomical Selection for LAAO: Should There Be Imaging Consensus Anatomical Criteria?

Equipoise Is a Myth: NOACs Will Be Superior to LAAO

ICE Imaging Is Not Ready for Prime-Time: TEE Should Be the Default Approach

ICE Imaging Should Be the Default Approach to LAAC Procedural Imaging

Oral Anticoagulation Should Be the Default Strategy After LAAC

Antiplatelet Therapy Is Sufficient for DRT Prevention After LAAC

PRAGUE-17: Three-Year Outcomes From a Randomized Trial of Left Atrial Appendage Closure Versus Direct Acting Oral Anticoagulation in Patients With Atrial Fibrillation

Captis: Full-Body Embolic Protection Device

Cerebral Protection in TAVR: The PROTEMBO C Trial

LAA Closure with the Laminar Device: technology and Clinical Update

Introducing XCLUDE Integrated Solution. World's First Dedicated LAA 3D Sizing Device and Next-Gen LAA Exclusion Device

Next Generation LAA Exclusion System to Reduce Stroke Risk in AF Patients (Append)

Featured Lecture: Clinical Outcomes of LAAO versus NOACS in Atrial Fibrillation in Patients with Prior Ischemic Stroke: Is There Room for Improvement in Clinical Outcomes?

TCT 703: Concomitant Transcatheter Mitral-Valve-in-Valve (MViV) with Left Atrial Appendage (LAA) Occlusion Device in a High-Risk Patient Unable to Tolerate Anticoagulation

TCT 692: Percutaneous Left atrial appendage occlusion after failed surgical closure with Left Atrial Appendage Epicardial Clip

TCT 691: Percutaneous Closure of Left Atrial Appendage With Suture Dehiscence Using ASD Closure Device Guided by a Novel Live 3D-ICE Probe

Percutaneous Left Atrial Appendage Closure Versus Oral Anticoagulation for Non-Valvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Right Ventricular-Pulmonary Arterial Coupling and Afterload Reserve in Patients Undergoing Transcatheter Tricuspid Valve Therapy: Insights From the International TriValve Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content